Ploidy Analysis and S‐Phase Fraction Determination by Flow Cytometry of Invasive Adenocarcinomas of the Breast

No abstract is available for this paper.

• Publication year

  1991

• Venue

  American Journal of Surgical Pathology

• Publication date

  1991-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00000478-199104000-00004PMID 2006715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA flow cytometry in primary breast carcinoma.

  2009cited by this paper
• Is DNA ploidy an independent prognostic indicator in infiltrative node‐negative breast adenocarcinoma?

  1990cited by this paper
• Assessment of proliferative rate of breast cancer by Ki-67 monoclonal antibody.

  1990cited by this paper
• DNA index and S‐phase fraction and their combination as prognostic factors in operable ductal breast carcinoma

  1990cited by this paper
• Nuclear DNA content as a prognostic factor in T1-2N0 breast cancer.

  1990cited by this paper
• Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations.

  1990cited by this paper
• DNA ploidy in breast lesions. A comparative study using two commercial image analysis systems and flow cytometry.

  1990cited by this paper
• Evaluation of cell proliferation in breast carcinoma. Comparison of Ki‐67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count

  1990cited by this paper
• The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients

  1990cited by this paper
• Cathepsin D and prognosis in breast cancer.

  1990cited by this paper
• Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and dna flow cytometry

  1990cited by this paper
• Indicators of prognosis in node-negative breast cancer.

  1990cited by this paper
• Prognostic significance of flow cytometric DNA analysis in node‐negative breast cancer patients

  1990cited by this paper
• Flow cytometry using paraffin-embedded tissue: five years on.

  1989cited by this paper
• The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer

  1989cited by this paper
• Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

  1989cited by this paper
• DNA aneuploidy and cell proliferation in breast tumors

  1989cited by this paper
• Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen.

  1989cited by this paper
• Different opinions on classification of DNA histograms produced from paraffin-embedded tissue.

  1989cited by this paper
• DNA flow cytometry in solid tumors: practical aspects and clinical applications.

  1989cited by this paper
• The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients.

  1989cited by this paper
• Breast cancer therapy: exercising all our options.

  1989cited by this paper
• Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression

  1989cited by this paper
• Cell kinetics of human tumors by in vitro bromodeoxyuridine labeling.

  1989cited by this paper
• Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.

  1989cited by this paper
• Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.

  1989cited by this paper
• Adjuvant therapy in node-negative breast cancer

  1989cited by this paper
• Factors affecting relapse in node-negative breast cancer. A multivariate analysis including the labeling index.

  1989cited by this paper
• DNA flow cytometry applied to fine needle sampling of human breast cancer

  1988cited by this paper
• Prognostic significance of dna measurements in 409 consecutive breast cancer patients

  1988cited by this paper
• Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis.

  1988cited by this paper
• Prognostic significance of DNA ploidy and proliferative index in breast carcinoma.

  1988cited by this paper
• Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas.

  1988cited by this paper
• Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S‐phase fraction: A proposed classification of DNA histograms in breast cancer

  1988cited by this paper
• Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptors

  1988cited by this paper
• Retrospective DNa analysis of T3/T4 breast carcinoma using cytophotometry and flow cytometry. A comparative study with prognostic evaluation.

  1988cited by this paper
• Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity.

  1988cited by this paper
• Correlation of dna flow cytometric results and other prognostic factors in primary breast cancer

  1988cited by this paper
• Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations.

  1988cited by this paper
• Flow cytometric analysis of ploidy in solid neoplasms: comparison of fresh tissues with formalin-fixed paraffin-embedded specimens.

  1988cited by this paper
• DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

  1988cited by this paper
• Relationship between flow cytometric parameters, steroid receptors, and menopausal status in breast cancers.

  1987cited by this paper
• DNA ploidy and survival in breast cancer patients.

  1987cited by this paper
• Influence of systematic errors on the evaluation of the S phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas.

  1987cited by this paper
• DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.

  1987cited by this paper
• Flow cytometric analysis for assessing the malignant potential of breast cancer

  1987cited by this paper
• Effect of tamoxifen upon cell DNA analysis by flow cytometry in primary carcinoma of the breast.

  1987cited by this paper
• Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.

  1987cited by this paper
• Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry.

  1987cited by this paper
• Tumour DNA ploidy as an independent prognostic factor in breast cancer.

  1987cited by this paper
• DNA analysis of breast tumour fine needle aspirates using flow cytometry.

  1987cited by this paper
• Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer.

  1987cited by this paper
• Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.

  1987cited by this paper
• Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer.

  1987cited by this paper
• Prognostic significance of the DNA content of human breast cancer

  1987cited by this paper
• The nuclear DNA content of human breast carcinoma. Associations with clinical stage, axillary lymph node status, estrogen receptor status and outcome.

  1987cited by this paper
• Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions.

  1987cited by this paper
• Differentiated DNA analysis in relation to steroid receptor status, grading, and staging in human breast cancer.

  1987cited by this paper
• Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma.

  1986cited by this paper
• A proposed classification of breast cancer based on kinetic information derived from a comparison of risk factors in 168 primary operable breast cancers

  1986cited by this paper
• Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics.

  1986cited by this paper
• Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer.

  1986cited by this paper
• DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma.

  1985cited by this paper
• Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer

  1985cited by this paper
• Cell kinetics as a prognostic marker in node‐negative breast cancer

  1985cited by this paper
• Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer.

  1985cited by this paper
• Correlation of cell‐cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer

  1984cited by this paper
• Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.

  1984cited by this paper
• Ploidy level of human breast carcinoma. Relation to histopathologic features and hormone receptor content.

  1984cited by this paper
• The proliferative index (PI) of human breast cancer as obtained by flow cytometry.

  1984cited by this paper
• Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement.

  1984cited by this paper
• Comparative flow DNA analysis of different cell suspensions in breast carcinoma.

  1984cited by this paper
• Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.

  1984cited by this paper
• The influence of age on the DNA ploidy levels of breast tumours.

  1983cited by this paper
• Long-term storage of samples for flow cytometric DNA analysis.

  1983cited by this paper
• Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

  1983cited by this paper
• Estrogen receptor content and ploidy of human mammary carcinoma

  1982cited by this paper
• Ploidy, proliferative activity and estrogen receptor content in human breast cancer.

  1982cited by this paper
• Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor

  1981cited by this paper
• Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor

  1981cited by this paper
• DNA content and survival in mammary carcinoma.

  1980cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Past, Present and Future of Flow Cytometry in Breast Cancer – A Systematic Review

  2019cites this paper
• JNK and Yorkie drive tumor progression by generating polyploid giant cells in Drosophila

  2018cites this paper
• Flow cytometric DNA hypertetraploidy tends to be more frequent in male than in female breast cancers

  2014influential citation
• Intratumoral Heterogeneity of Immunohistochemical Marker Expression in Breast Carcinoma: A Tissue Microarray-based Study

  2010cites this paper
• CHAPTER 19 – Breast

  2009cites this paper
• -1993-A CASE OF APOCRINE CARCINOMA OF THE BREAST DEVELOPED IN A CYSTIC FORM of

  2008cites this paper
• DNA flow cytometry of canine mammary tumors : comparative aspects with human breast tumors

  2007influential citation
• Intratumoral Heterogeneity of HER2/neu in Breast Cancer—A Rare Event

  2007cites this paper
• DNA flow cytometry of canine mammary tumors: comparative aspects with human breast tumors (Citometria de fluxo de DNA em tumores mamários da cadela:aspectos comparativos com tumores mamários humano)

  2007cites this paper
• DNA flow cytometry of canine mammary tumors: comparative aspects with human breast tumors

  2007cites this paper
• Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisation

  2006cites this paper
• S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers

  2005influential citation
• HER-2/neu expression as a predictive factor for response to anthracycline-based chemotherapy in a Mexican Population of locally advanced breast cancer patients

  2005cites this paper
• Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas — a 10 year survival study

  2005cites this paper
• Outcome and human epidermal growth factor receptor (HER) 1–4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling

  2004cites this paper
• low-up of a large series of patients with advanced breast cancer was to evaluate the independent prognostic value of hormone receptor expression and DNA flow cytome-

  2003cites this paper
• DNA ploidy and cell cycle analysis in breast cancer.

  2003cites this paper
• S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.

  2003cites this paper
• Overall survival in advanced breast cancer: relevance of progesterone receptor expression and DNA ploidy in fine-needle aspirates of 392 patients.

  2003cites this paper
• Prognostic value of flow-cytometric DNA analysis in breast cancer

  2002cites this paper
• Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer.

  2002cites this paper
• Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma.

  2001cites this paper
• Lack of Prognostic Value With 12-Year Follow-up

  2001cites this paper
• Proliferative Activity in Invasive Breast Carcinoma

  2001cites this paper
• Biopathological significance of single cell DNA aneuploidy measured by static cytometry in breast cancer.

  2001cites this paper
• Flow Cytometric DNA Analysis Using Cytokeratin Labeling for Identification of Tumor Cells in Carcinomas of the Breast and the Female Genital Tract

  2001cites this paper
• Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.

  2001cites this paper
• Relationship of DNA ploidy to hormone receptor status and proliferation in invasive breast carcinoma

  2000cites this paper
• A novel flow cytometric steroid hormone receptor assay for paraffin-embedded breast carcinomas: an objective quantification of the steroid hormone receptors and direct correlation to ploidy status and proliferative capacity in a single-tube assay.

  2000cites this paper
• Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours

  2000cites this paper
• Low-stage carcinoma of the male breast. A histologic, immunohistochemical, and flow cytometric comparison with localized female breast carcinoma.

  1999cites this paper
• Independent prognostic factors in breast cancer patients.

  1998cites this paper
• Is primary chemotherapy useful for all patients with primary invasive breast cancer?

  1998cites this paper
• The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer.

  1998cites this paper
• Flow cytometry in breast cancer: prognostic and surgical indications of the sparing of axillary lymph node dissection.

  1998cites this paper
• New aspects in the histological diagnosis of breast carcinoma.

  1998cites this paper
• Prognostic value of DNA ploidy in breast cancer stage I-II.

  1997cites this paper
• [DNA cytometry in breast carcinoma. Review of method and value in assessing prognosis].

  1997cites this paper
• Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer.

  1997cites this paper
• Medullary Carcinoma of the Breast

  1997cites this paper
• Fluorescence in situ hybridization assessment of chromosome 8 copy number in stage I and stage II infiltrating ductal carcinoma of the breast.

  1997cites this paper
• Ploidy level determination and quantitative chromatin pattern description in pregnancy-associated breast cancers

  1997cites this paper
• Correlation Among MIB-1, Paraffin Section Proliferation Index, and Recurrence in Low-Stage Breast Carcinoma

  1997cites this paper
• DNA-Zytometrie beim Mammakarzinom Übersicht zur Methode und zum Stellenwert bei der Prognoseabschätzung

  1997cites this paper
• Agnor Counts and their Combination with flow Cytometric Analyses and Clinical Parameters as a Prognostic Indicator in Breast Carcinoma

  1997cites this paper
• DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast.

  1996cites this paper
• Assessment of Proliferative Activity of Glandular Cells in Hyperfunctioning Parathyroid Gland Using Flow Cytometric and Immunohistochemical Methods

  1996cites this paper
• Cytokinetic investigations in human breast cancer by flow cytometrically recorded DNA/protein distributions.

  1996cites this paper
• The effect of number of histogram events on reproducibility and variation of flow cytometric proliferation measurement.

  1996cites this paper
• Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma.

  1996cites this paper
• Cell kinetics in vivo of human breast cancer

  1996cites this paper
• Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content.

  1996cites this paper
• Breast tumour response to primary chemotherapy predicts local and distant control as well as survival.

  1995cites this paper
• Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biology.

  1995cites this paper
• Image analysis evaluation of ploidy, S-phase fraction and nuclear area in canine mammary tumours.

  1995cites this paper
• Intratumoral heterogeneity of DNA ploidy in breast carcinomas: a flow cytometric assessment of sampling techniques.

  1995cites this paper
• Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions.

  1995cites this paper
• Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance?

  1995cites this paper
• An analysis of prognostic features in infiltrating lobular carcinoma of the breast.

  1995cites this paper
• Immunohistochemical and flow cytometric study of neuroendocrine carcinoma of the skin

  1995cites this paper
• Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.

  1995cites this paper
• DNA flow cytometry of canine mammary tumours: the relationship of DNA ploidy and S-phase fraction to clinical and histological features.

  1995cites this paper
• Prognostic Factors for Carcinoma of the Male Breast

  1995cites this paper
• DNA Ploidy as a Significant Predictor of Recurrence‐Free Survival in Male Patients with Breast Cancer

  1995cites this paper
• Digital cell image analysis of Feulgen-stained nuclei from human papillary, medullary, colloid, lobular and comedocarcinomas of the breast.

  1994cites this paper
• Carcinoembryonic antigen and estrogen receptor

  1994cites this paper
• Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.

  1994cites this paper
• Introduction of the cytological grading, the nuclear area, the DNA index and the DNA histogram type in the setting up of a score for ductal breast carcinoma.

  1994cites this paper
• Carcinoembryonic antigen and estrogen receptor. A prognostic duo in breast cancer?

  1994cites this paper
• Secretory carcinoma of the breast: light microscopical, immunohistochemical and flow cytometric study.

  1994cites this paper
• Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for identification of tumour cells.

  1994cites this paper
• Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.

  1994cites this paper
• Correlation between immunohistochemical expression of proliferating cell nuclear antigen and flow cytometry parameters in colorectal neoplasia

  1994cites this paper
• [Breast cancer and flow cytometry: comparative study of DNA ploidy pattern with clinicopathological parameters].

  1994cites this paper
• Status of breast cancer prognostication based on histopathologic data.

  1994cites this paper
• A CASE OF APOCRINE CARCINOMA OF THE BREAST DEVELOPED IN A CYSTIC FORM

  1994cites this paper
• AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.

  1994cites this paper
• DNA histogram typing and DNA index measurements in 508 invasive breast carcinomas from fine-needle aspirates and imprint smears as opposed to formalin-fixed paraffin-embedded tissues.

  1994cites this paper
• S‐phase fraction and nuclear size in long term prognosis of patients with breast cancer

  1994cites this paper
• Pathologic correlates of prognosis in lymph node‐positive breast carcinomas

  1993cites this paper
• Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer.

  1993cites this paper
• Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer.

  1993cites this paper
• Milwaukee's water woes.

  1993cites this paper
• Relationships between image cytometric DNA index, proliferation fraction and multiploidy and conventional nuclear grade in breast carcinoma.

  1993cites this paper
• Spontaneous abortions and DNA ploidy. An application of flow cytometric DNA analysis in detection of non-diploidy in early abortions.

  1993cites this paper
• Grade and flow cytometric analysis of ploidy for infiltrating ductal carcinomas.

  1993cites this paper
• Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer.

  1993cites this paper
• DNA Histogram Typing in a Series of 707 Tumors of the Central and Peripheral Nervous System

  1993cites this paper
• [The application of cytofluorometry to solid tumors for measuring DNA and the S phase].

  1993cites this paper
• A comparative study of DNA quantitation in breast carcinoma with image cytometric analysis and in vitro fine-needle aspiration with flow cytometric analysis.

  1993cites this paper
• Relationship between proliferative activity and ploidy level in a series of 530 human brain tumors, including astrocytomas, meningiomas, schwannomas, and metastases.

  1993cites this paper
• Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1.

  1993cites this paper
• Predictive value of a morphometric prognostic index in female breast cancer.

  1993cites this paper
• Flow cytometric (DNA content and S‐phase fraction) analysis of breast cancer

  1993cites this paper
• DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer

  1992cites this paper
• Modification of tumor ploidy level via the choice of tissue taken as diploid reference in the digital cell image analysis of Feulgen-stained nuclei.

  1992cites this paper
• DNA flow cytometry in the assessment of solid neoplasms.

  1992cites this paper
• Liver ploidy.

  1992cites this paper
• Characterization of nuclear size, ploidy, DNA histogram type and proliferation index in 79 nerve sheath tumors.

  1992cites this paper
• Mitotic indexes as indicators of malignancy in human tumors.

  1992cites this paper